Authors/Disclosures
|
Petra Kaufmann, MD, FAAN
(Affinia Therapeutics)
|
Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities. |
|
John L. Thompson, PhD
(Columbia Univ School of Public Health)
|
The institution of Dr. Thompson has received research support from NIH. |
|
Gilberto Levy, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Bruce I. Ovbiagele, MD, MSc, FAAN
(San Francisco VA)
|
Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities. |
|
Richard Buchsbaum
|
No disclosure on file |
|
Jacqueline Montes, PT, EdD, NCS
(Columbia University Medical Center)
|
Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA. |
|
Rachel Arbing
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Vanessa Battista
(The Children'S Hospital of Philadelphia)
|
No disclosure on file |
|
Paul H. Gordon, MD, PhD, FAAN
|
No disclosure on file |
|
Hiroshi Mitsumoto, MD, FAAN
(Neurological Institute (NI-9))
|
Dr. Mitsumoto has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |